Literature DB >> 15277222

Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.

Tiemo Katzenberger1, German Ott, Thomas Klein, Jörg Kalla, Hans Konrad Müller-Hermelink, M Michaela Ott.   

Abstract

Recently, classical banding cytogenetic studies suggested that follicular lymphomas (FLs) grade 3 with preserved maturation to centrocytes (FL3A) are closely related to FL grades 1 and 2 and frequently harbor the t(14;18), whereas FL grade 3B, consisting of centroblasts exclusively, do frequently show 3q27 alterations. To clarify the prevalence of BCL6 and BCL2 rearrangements in FL and diffuse large B-cell lymphomas (DLBLs), we performed a large scale bicolor interphase cytogenetic (fluorescence in situ hybridization) study on 188 well-characterized B-NHLs classified according to the World Health Organization Classification of Tumors of the Lymphoid Tissues. BCL6 rearrangements were detected in a significantly higher number of FL3B with a DLBL component (12 of 22, 55%) compared with purely diffuse nodal DLBLs (19 of 77, 25%) and DLBLs with a well-documented primary extranodal origin (2 of 27, 7%) (P < 0.001). Five FL3B without a DLBL component were negative for both t(14;18) and 3q27 aberrations. FL grades 1/2 and FL3A were t(14;18)-positive in 88% and 64% of cases, respectively, but 3q27 alterations were identified in only four FL3A. These data exemplify different genetic pathways in the genesis of FLs with a high content of centroblasts and suggest that 3q27 rearrangements are predominantly associated with FL grade 3B harboring a DLBL component.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277222      PMCID: PMC1618575          DOI: 10.1016/S0002-9440(10)63313-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

1.  LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients.

Authors:  C Bastard; C Deweindt; J P Kerckaert; B Lenormand; A Rossi; F Pezzella; C Fruchart; C Duval; M Monconduit; H Tilly
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

2.  Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein.

Authors:  T Miki; N Kawamata; S Hirosawa; N Aoki
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

3.  Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.

Authors:  B H Ye; F Lista; F Lo Coco; D M Knowles; K Offit; R S Chaganti; R Dalla-Favera
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

4.  Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3.

Authors:  German Ott; Tiemo Katzenberger; Andreas Lohr; Steffi Kindelberger; Thomas Rüdiger; Martin Wilhelm; Jörg Kalla; Andreas Rosenwald; Justus G Müller; M Michaela Ott; Hans Konrad Müller-Hermelink
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

5.  Production of tumor necrosis factor and other proinflammatory cytokines by human mononuclear phagocytes stimulated with myelin P2 protein.

Authors:  P Baron; G Constantin; A D'Andrea; D Ponzin; E Scarpini; G Scarlato; G Trinchieri; F Rossi; M A Cassatella
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

6.  Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.

Authors:  K Offit; F Lo Coco; D C Louie; N Z Parsa; D Leung; C Portlock; B H Ye; F Lista; D A Filippa; A Rosenbaum
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

7.  Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias.

Authors:  T Miki; N Kawamata; A Arai; K Ohashi; Y Nakamura; A Kato; S Hirosawa; N Aoki
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

8.  Follicular large-cell lymphoma: intermediate or low grade?

Authors:  N L Bartlett; M Rizeq; R F Dorfman; J Halpern; S J Horning
Journal:  J Clin Oncol       Date:  1994-07       Impact factor: 44.544

9.  Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma.

Authors:  F Lo Coco; B H Ye; F Lista; P Corradini; K Offit; D M Knowles; R S Chaganti; R Dalla-Favera
Journal:  Blood       Date:  1994-04-01       Impact factor: 22.113

10.  Prognostic value of cellular proliferation and histologic grade in follicular lymphoma.

Authors:  A R Martin; D D Weisenburger; W C Chan; E I Ruby; J R Anderson; J M Vose; P J Bierman; M A Bast; D T Daley; J O Armitage
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

View more
  17 in total

1.  Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study.

Authors:  Patrizia Mondello; Normann Steiner; Wolfgang Willenbacher; Claudio Cerchione; Davide Nappi; Endri Mauro; Simone Ferrero; Salvatore Cuzzocrea; Michael Mian
Journal:  Oncologist       Date:  2018-01-09

2.  Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.

Authors:  J Iqbal; T C Greiner; K Patel; B J Dave; L Smith; J Ji; G Wright; W G Sanger; D L Pickering; S Jain; D E Horsman; Y Shen; K Fu; D D Weisenburger; C P Hans; E Campo; R D Gascoyne; A Rosenwald; E S Jaffe; J Delabie; L Rimsza; G Ott; H K Müller-Hermelink; J M Connors; J M Vose; T McKeithan; L M Staudt; W C Chan
Journal:  Leukemia       Date:  2007-07-12       Impact factor: 11.528

3.  Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.

Authors:  Ana Borovecki; Petra Korać; Marin Nola; Davor Ivanković; Branimir Jaksić; Mara Dominis
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

Review 4.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

5.  Follicular lymphoma grade 3B: is it a real disease?

Authors:  Nancy Lee Harris; Philip Kluin
Journal:  Haematologica       Date:  2011-09       Impact factor: 9.941

6.  [Extranodal diffuse large B-cell lymphoma--an organotypic disease?].

Authors:  G Ott; A Rosenwald
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

7.  CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases.

Authors:  Yu Li; Shimin Hu; Zhuang Zuo; Ming Hong; Pei Lin; Shaoying Li; Sergej Konoplev; Zhen Wang; Joseph D Khoury; Ken H Young; L Jeffrey Medeiros; C Cameron Yin
Journal:  Mod Pathol       Date:  2015-03-06       Impact factor: 7.842

8.  Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.

Authors:  Heike Horn; Christopher Schmelter; Ellen Leich; Itziar Salaverria; Tiemo Katzenberger; M Michaela Ott; Jörg Kalla; Monica Romero; Reiner Siebert; Andreas Rosenwald; German Ott
Journal:  Haematologica       Date:  2011-06-09       Impact factor: 9.941

9.  miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.

Authors:  Mary Ann Thompson; Mick D Edmonds; Shan Liang; Sara McClintock-Treep; Xuan Wang; Shaoying Li; Christine M Eischen
Journal:  Hum Pathol       Date:  2015-11-30       Impact factor: 3.466

10.  t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.

Authors:  Keni Gu; Kai Fu; Smrati Jain; Zhongfen Liu; Javeed Iqbal; Min Li; Warren G Sanger; Dennis D Weisenburger; Timothy C Greiner; Patricia Aoun; Bhavana J Dave; Wing C Chan
Journal:  Mod Pathol       Date:  2009-05-22       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.